Bicara Therapeutics Common Stock Statistics Share Statistics Bicara Therapeutics Common Stock has 54.56M
shares outstanding. The number of shares has increased by 0.27%
in one year.
Shares Outstanding 54.56M Shares Change (YoY) 0.27% Shares Change (QoQ) 0.05% Owned by Institutions (%) 93.81% Shares Floating 30.93M Failed to Deliver (FTD) Shares 8,534 FTD / Avg. Volume 2.2%
Short Selling Information The latest short interest is 5.67M, so 10.39% of the outstanding
shares have been sold short.
Short Interest 5.67M Short % of Shares Out 10.39% Short % of Float 16.26% Short Ratio (days to cover) 20.22
Valuation Ratios The PE ratio is -13.94 and the forward
PE ratio is -6.38.
Bicara Therapeutics Common Stock's PEG ratio is
-0.56.
PE Ratio -13.94 Forward PE -6.38 PS Ratio 0 Forward PS n/a PB Ratio 1.93 P/FCF Ratio -12.67 PEG Ratio -0.56
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Bicara Therapeutics Common Stock.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 27.93,
with a Debt / Equity ratio of 0.
Current Ratio 27.93 Quick Ratio 27.93 Debt / Equity 0 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.24M Employee Count 55 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 187K Effective Tax Rate -0.28%
Stock Price Statistics The stock price has increased by -32.27% in the
last 52 weeks. The beta is -0.78, so Bicara Therapeutics Common Stock's
price volatility has been lower than the market average.
Beta -0.78 52-Week Price Change -32.27% 50-Day Moving Average 11.83 200-Day Moving Average 12.49 Relative Strength Index (RSI) 79.4 Average Volume (20 Days) 388,509
Income Statement
Revenue n/a Gross Profit -56K Operating Income -82.39M Net Income -68M EBITDA -67.75M EBIT -67.81M Earnings Per Share (EPS) -1.25
Full Income Statement Balance Sheet The company has 489.71M in cash and 738K in
debt, giving a net cash position of 488.97M.
Cash & Cash Equivalents 489.71M Total Debt 738K Net Cash 488.97M Retained Earnings -221.02M Total Assets 453.59M Working Capital 427.16M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -74.75M
and capital expenditures -71K, giving a free cash flow of -74.82M.
Operating Cash Flow -74.75M Capital Expenditures -71K Free Cash Flow -74.82M FCF Per Share -1.37
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
